HYPR(Hyperfine, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.50M | $6.81M | $11.03M | $12.89M | $13.56M |
| 毛利润 | −$1.17M | $907.00K | $4.76M | $5.89M | $6.75M |
| 营业利润 | −$64.87M | −$73.87M | −$48.12M | −$43.22M | −$37.09M |
| 净利润 | −$64.85M | −$44.24M | −$44.24M | −$40.72M | −$35.57M |
| 经营现金流 | −$47.18M | −$72.34M | −$41.81M | −$38.77M | −$27.95M |
| 自由现金流 | −$49.89M | −$72.92M | −$42.61M | −$39.15M | −$29.13M |
| 摊薄每股收益 | $-17.57 | $-1.04 | $-0.62 | $-0.56 | $-0.43 |